Skip to main content
Signal8

MIDDLEKAUFF W BRADFORD

SEC insider (Form 3/4/5 filer). CIK 0001214501. Director at Amanat Acquisition Corp. (AMAN) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Oct 28, 2025. Located in NEW YORK, NY.

Companies MIDDLEKAUFF W BRADFORD has filed insider reports for

  • Amanat Acquisition Corp. (AMAN): Director
  • Tourmaline Bio, Inc. (TRML): Officer, CBO, GC and Secretary
MIDDLEKAUFF W BRADFORD profile photo

MIDDLEKAUFF W BRADFORD

CIK: 0001214501

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)2 (66.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Amanat Acquisition Corp. logo
AMAN

Amanat Acquisition Corp.

Director
Tourmaline Bio, Inc. logo
TRML

Tourmaline Bio, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Tourmaline Bio, Inc. logo
    TRML

    Tourmaline Bio, Inc.

    Oct 28, 2025
    Tender Offer
    Direct
    61K shares-
  • Tourmaline Bio, Inc. logo
    TRML

    Tourmaline Bio, Inc.

    Oct 28, 2025
    Disposition
    Direct
    8.2K shares-
  • Tourmaline Bio, Inc. logo
    TRML

    Tourmaline Bio, Inc.

    Jan 27, 2025
    Award

    Employee Stock Option (Right to Buy)

    Direct
    58K shares-

1-3 of 3